Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Inventory (2020 - 2025)

Universe Pharmaceuticals' Inventory history spans 6 years, with the latest figure at $2.5 billion for Q3 2025.

  • On a quarterly basis, Inventory rose 43.33% to $2.5 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $2.5 billion, a 43.33% increase, with the full-year FY2025 number at $2.5 billion, up 43.33% from a year prior.
  • Inventory hit $2.5 billion in Q3 2025 for Universe Pharmaceuticals, up from $1.7 billion in the prior quarter.
  • Over the last five years, Inventory for UPC hit a ceiling of $2.5 billion in Q3 2025 and a floor of $16701.0 in Q3 2022.
  • Historically, Inventory has averaged $529.9 million across 5 years, with a median of $3.1 million in 2022.
  • Biggest five-year swings in Inventory: tumbled 100.0% in 2021 and later surged 961494.97% in 2024.
  • Tracing UPC's Inventory over 5 years: stood at $2.5 million in 2021, then plummeted by 99.32% to $16701.0 in 2022, then soared by 981.63% to $180643.0 in 2023, then surged by 961494.97% to $1.7 billion in 2024, then surged by 43.33% to $2.5 billion in 2025.
  • Business Quant data shows Inventory for UPC at $2.5 billion in Q3 2025, $1.7 billion in Q3 2024, and $3.4 million in Q1 2024.